School of Medicine
Showing 131-140 of 386 Results
-
Philip Fernandes
Masters Student in Translational Research and Applied Medicine, admitted Autumn 2026
Fellow in Pediatrics - GastroenterologyBioI am a Clinical Fellow in Pediatric Gastroenterology, Hepatology, and Nutrition and a Tashia and John Morgridge Endowed Postdoctoral Fellow at Stanford University and Lucile Packard Children’s Hospital, supported by the Maternal & Child Health Research Institute. I completed my residency at Henry Ford St. John Hospital in Detroit, where caring for diverse communities shaped my dedication to health equity and cultural humility.
In the Rosen Lab, my research centers on pediatric ulcerative colitis (UC). I use 3D colonoids—lab-grown models of the colon derived from intestinal stem cells—alongside single-cell genomic technologies to map cellular metabolic changes and cell-to-cell interactions. By decoding these cellular dynamics, my goal is to uncover targeted, precise therapies that better control disease, prevent complications, and support long-term growth, nutrition, and overall health for pediatric patients.
This work builds on my foundation in pediatric gastroenterology at the University of Virginia’s Syed Lab, where I contributed to data interpretation, grant development, and multi-institutional research integrating genomics and machine learning to investigate gastrointestinal structure and function.
As a student in the Master's in Translational Research and Applied Medicine (M-TRAM) program, I am building actionable skills across clinical medicine, translational research, and industry-driven approaches to innovation, preparing to advance therapeutics for complex pediatric enteropathies. -
Nielsen Fernandez-Becker
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioI am the director of the Celiac Disease Program at Stanford and I am highly experienced in diagnosis and management of celiac disease and gluten associated disorders.
My objective is to provide excellent and compassionate clinical care for my patients while seeking a better understanding of diseases I treat, particularly Celiac disease (CeD), eosinophilic esophagitis (EoE). My top priorities are patient care and translational research to make new discoveries and improve the care my patients. -
Marcelo Fernandez Vina
Professor of Pathology
BioMarcelo Fernández-Viña, Ph.D., D (ABHI) is a Professor for the Department of Pathology at Stanford University Medical School and serves as Director of the Histocompatibility, Immunogenetics and Disease Profiling Laboratory at this institution. He has been working in the fields of Histocompatibility and Immunogenetics since 1982. He earned a degree in Biochemistry from the School of Basic Sciences in Rosario, Argentina, and his Ph.D. in Internal Medicine from the University of Buenos Aires Medical School in Argentina. Previously he held a position as a Professor in the Department of Laboratory Medicine at the University of Texas M.D. Anderson Cancer Center in Houston. He has more than 180 peer reviewed publications, many of them focusing on HLA variation in multiple world populations, identifying susceptibility and resistance factors for diseases and in the impact of HLA mismatches in allogeneic transplantation; and 59 book chapters. He served as expert Consultant for Donor Searches for NMDP and as President Elect, President and Past President of the American Society for Histocompatibility and Immunogenetics. He served as a member of the Board of Directors and the Executive Committee for the United Network for Organ Sharing. He served as Co-Chair of the Immunobiology Committee of the CIBMTR; He also served as a member of the HHS Advisory Council on Blood Stem Cell Transplantation (ACBSCT).He serves as HLA Expert Consultant for the NMDP for the HRSA contract and is a member of the Histocompatibility Advisory Group for NMDP. He is Councilor of the International Histocompatibility Workshop and a member of the WHO Nomenclature Committee for Factors of the HLA System and was Chairman of the (17th) International HLA & Immunogenetics Workshop, and Past President of the International HLA & Immunogenetics Workshop.
-
Juan Carlos Fernandez-Miranda, MD, FACS
Professor of Neurosurgery and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)
BioDr. Juan Fernandez-Miranda is Professor of Neurosurgery and Surgical Director of the Stanford Brain Tumor, Skull Base, and Pituitary Centers. He is internationally renowned for his expertise in minimally invasive brain surgery, endoscopic skull base and pituitary surgery, open skull base surgery, and complex brain tumor surgery. He has performed over 4,000 cranial operations including more than 2,000 endoscopic endonasal operations for pituitary tumors and other skull base lesions. He is highly regarded for his innovative contributions to the development and refinement of endoscopic endonasal skull base surgery, for his ability to select the most effective and less invasive approach to each individual patient, and for his precise knowledge of the intricate anatomy of the white matter tracts required to maximize resection and minimize morbidity on high and low grade glioma patients. He has been recently ranked by Expertscape as World-Expert (top 0.05%) on Skull Base Surgery and #1 Neurosurgeon Expert on Skull Base Tumors (pituitary adenomas, meningiomas, craniopharyngiomas, chordomas, chondrosarcomas, schwannomas and esthesioneuroblastomas) on the US Pacific Region. He is co-founder and vice-president of the International Rhoton Society and executive member of the Board of Directors of the The Neurosurgical Atlas, the largest nonprofit organization for neurosurgical education and research in the world.
Dr. Fernandez-Miranda completed neurosurgery residency at La Paz University Hospital in Madrid, Spain. Upon completion of his residency, he was awarded the Sanitas Prize to the best medical postgraduate trainee in the country. From 2005 to 2007, he underwent fellowship training in microsurgical neuroanatomy at the University of Florida under legendary neurosurgeon Albert L. Rhoton, Jr. From 2007 to 2010 he continued subspecialty clinical training in cerebrovascular surgery at the University of Virginia, and endoscopic endonasal and open skull base surgery at University of Pittsburgh Medical Center (UPMC). During his 10-year tenure at UPMC, he pioneered endoscopic endonasal approaches to highly complex pituitary and skull base tumors, developed a world-class complex brain surgery program, and led a premier training and research program on surgical neuroanatomy and skull base surgery.
In 2018, he was recruited to bring to Stanford his unique technical expertise and to collaborate with world-renowned Stanford colleagues across multiple disciplines, leading the establishment of one of the most preeminent centers worldwide for comprehensive treatment of complex lesions in the brain, skull base, and pituitary regions. His top priority is to provide gentle, accurate, and safe surgery, in a team-based and compassionate approach to patient care.
